Application 021342

Type
NDA
Sponsor
CEDIPROF INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
002LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
003LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
004LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
005LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
006LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
007LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
008LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
009LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
010LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
011LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
012LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021342-001LEVO-TLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-002LEVO-TLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-003LEVO-TLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-004LEVO-TLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-005LEVO-TLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-006LEVO-TLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-007LEVO-TLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-008LEVO-TLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-009LEVO-TLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-010LEVO-TLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-011LEVO-TLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-012LEVO-TLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 36 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 14 · 540 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-08d4dbc9d85df4…
2026-10-15 13:18:302026-09N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01c2088c7a36db…
2026-10-15 13:18:302026-09N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-08c2088c7a36db…
2026-09-14 22:38:342026-08N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0184e616aacf4f…
2026-09-14 22:38:342026-08N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-0884e616aacf4f…
2026-08-18 06:07:402026-07N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01caaa826d4ba7…
2026-08-18 06:07:402026-07N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01caaa826d4ba7…
2026-08-18 06:07:402026-07N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01caaa826d4ba7…
2026-08-18 06:07:402026-07N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01caaa826d4ba7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 41 · 1,620 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N021342-001AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-001AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-001AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-002AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-002AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-002AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-003AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-003AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-003AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-004AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-004AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-004AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-005AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-005AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-005AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-006AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-006AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-006AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-007AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-007AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-007AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-008AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-008AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-008AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-009AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-009AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-009AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-010AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-010AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-010AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-011AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-011AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-011AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-012AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-012AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10N021342-012AB33d4dbc9d85df4…
2026-10-15 13:18:302026-09N021342-001AB11c2088c7a36db…
2026-10-15 13:18:302026-09N021342-001AB22c2088c7a36db…
2026-10-15 13:18:302026-09N021342-001AB33c2088c7a36db…
2026-10-15 13:18:302026-09N021342-002AB11c2088c7a36db…

Observed Orange Book patent history#

Patent history page 1 of 2 · 66 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2019-12-13 00:20 UTC2019-12N021342-00163991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00263991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00363991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00463991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00563991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00663991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00763991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00863991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00963991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-01063991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-01163991012020-03-3074a2ff9319b5…
2020-12-22 03:56 UTC2020-12N021342-00163991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00263991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00363991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00463991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00563991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00663991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00763991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00863991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00963991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-01063991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-01163991012020-03-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021342-00163991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00263991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00363991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00463991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00563991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00663991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00763991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00863991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00963991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-01063991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-01163991012020-03-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021342-00163991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00263991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00363991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00463991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00563991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00663991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00763991012020-03-303f01610625f2…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 3 · 48 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack66bb0ba9-cd63-4817-907f-7b8ad5dc66852026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
ndc (product): 63629-2088
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack8ac112c3-1e06-4fdb-a7af-2ee988de5b152026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack69fb5cd6-90ba-487d-a754-07c664a1fdd12026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
ndc (product): 63629-2090
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf6c92836-95e1-1402-e053-6394a90a2f5e2026-01-19Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMLannett Company, Inca8db0f7d-8863-9309-e053-2995a90a284a2026-01-08Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf31b5d54-7536-4290-e053-2a95a90ac2352026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf32b4a01-edea-fc85-e053-2995a90ac1752026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf31a35cb-fc54-8872-e053-2a95a90ad8e72026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf31ba297-e042-187a-e053-2a95a90a48612026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf31d987d-6836-b4a7-e053-2a95a90a8f7b2026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf86e74e1-0d55-8d0e-e053-6394a90a07bf2026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf86efc89-f784-c8bb-e053-6294a90a63c92026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCdb9821db-3fe3-d1cf-e053-2a95a90a02522026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCf86fab39-bbd9-a51c-e053-6294a90accd02026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMCoupler LLC472ec9e7-c1db-bf8c-e063-6394a90a2c072025-12-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMCoupler LLC4302e36f-0b5b-f645-e063-6394a90a010f2025-11-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP9e588c43-b9b5-478e-99f7-e197add3cd262025-08-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions91afb351-f067-49a2-bdf0-336ea209718d2025-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions237cc591-c40b-416f-ac00-96cd61bc59dc2025-05-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack8f83fd60-5aa7-4e7f-a6e9-917e2c1abf272024-08-21Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 2 of 5 · 350 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51655-295Levothyroxine SodiumLevothyroxine SodiumNorthwind PharmaceuticalsNDACurrent
51655-299LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNorthwind Pharmaceuticals, LLCNDACurrent
51655-749Levothyroxine SodiumLevothyroxine SodiumNorthwind Pharmaceuticals, LLCNDACurrent
53808-1115Levothyroxine sodiumLevothyroxine sodiumDOH CENTRAL PHARMACYNDA AUTHORIZED GENERICCurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
61919-197Levothroxine SodiumLevothroxine SodiumDirect_RxNDA AUTHORIZED GENERICCurrent
61919-466LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-466LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-549LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-549LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-810LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-810LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-816LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-816LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-870LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-870LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-872LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirectRxNDA AUTHORIZED GENERICCurrent
61919-872LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
63187-851Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-851Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-982Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-982Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2088Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2088Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2089Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2089Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2090Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85838SUPPL 2026-05-21
85864SUPPL 2026-05-11
50625SUPPL2017-12-07
50624SUPPL2017-12-07
27524SUPPL2011-03-11
15222SUPPL2009-06-22
27523SUPPL2009-06-17
27522SUPPL2008-06-13
27521SUPPL2008-06-13
36694SUPPL2008-06-12
15221SUPPL2008-06-12
42112SUPPL2005-05-13
42111SUPPL2005-05-13
5088SUPPL2004-06-24
5087SUPPL2004-06-24
36692SUPPL2003-12-11
5085SUPPL2003-12-11
36693SUPPL2003-08-28
5086SUPPL2003-08-28
69369ORIG2002-06-19
21609ORIG2002-06-19
27520ORIG2002-03-01
15220ORIG2002-03-01